Neoleukin rises after Millenium Management discloses 5% passive stake

Neurogene

19/07/2022 23:07

** Biopharmaceutical company Neoleukin Therapeutics shares
up 2.4% at $1.26 in extended trade
    ** Co reports 5% passive stake by millennium Management LLC
as of July 18
    ** NLTX closed at 3rd straight session of gains at $1.23
    ** Up to Tuesday's close, stock had fallen 74.48% YTD

 (Reporting by Shreyaa Narayanan in Bengaluru)
 ((Shreyaa.Narayanan@thomsonreuters.com))